HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Henry M Sondheimer Selected Research

motavizumab (Numax)

8/2011A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Henry M Sondheimer Research Topics

Disease

3Congenital Heart Defects (Congenital Heart Defect)
08/2011 - 10/2003
2Vascular Diseases (Vascular Disease)
11/2004 - 05/2003
1Mumps
03/2011
1Whooping Cough (Pertussis)
03/2011
1Rubella (German Measles)
03/2011
1Chickenpox
03/2011
1Hepatitis B
03/2011
1Human Influenza (Influenza)
03/2011
1Measles
03/2011
1Hypoplastic Left Heart Syndrome
05/2003

Drug/Important Bio-Agent (IBA)

3PalivizumabFDA Link
08/2011 - 10/2003
1motavizumab (Numax)IBA
08/2011
1VaccinesIBA
03/2011
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
03/2011

Therapy/Procedure

2Heart Transplantation (Grafting, Heart)
11/2004 - 05/2003
1Fontan Procedure (Fontan Operation)
11/2004